Myo-inositol and D-chiro-inositol are two forms of inositol, a naturally occurring sugar alcohol that plays a central role in how your cells respond to insulin and other hormones. They’re closely related but do different things in the body: myo-inositol primarily supports ovarian function and helps cells absorb glucose, while D-chiro-inositol focuses on glucose storage and androgen production. Most supplements combine them in a 40:1 ratio, which mirrors the proportion found naturally in human blood plasma.
How Inositol Works in Your Cells
Inositol isn’t a vitamin, though it was once called vitamin B8. Your body makes it from glucose, and you also get it from foods like fruits, beans, grains, and nuts. It sits in your cell membranes and acts as a building block for signaling molecules that relay messages from hormones, especially insulin, to the inside of your cells.
When insulin docks onto a cell’s receptor, it triggers the release of small molecules called inositol phosphoglycans. These molecules come in two types: one built from myo-inositol and one from D-chiro-inositol. Both act as second messengers, essentially carrying insulin’s instructions deeper into the cell so metabolic processes can actually happen. Without adequate inositol, the insulin signal weakens, even if your body is producing plenty of insulin.
What Each Form Does Differently
Myo-inositol is the more abundant form, making up roughly 99% of the inositol in your body. It participates in a wide range of signaling pathways: it helps move glucose transporters to cell surfaces so cells can absorb sugar from the blood, it reduces free fatty acid release from fat tissue, and it strengthens how ovarian cells respond to follicle-stimulating hormone (FSH). In the ovaries specifically, myo-inositol supports the enzyme aromatase, which converts androgens into estrogen, a process essential for healthy egg maturation.
D-chiro-inositol plays a narrower but complementary role. It enhances glycogen storage by boosting the enzyme glycogen synthase, which is why your liver and muscles, tissues that store large amounts of glycogen, contain higher concentrations of it. It also speeds up the oxidative breakdown of glucose for energy. In ovarian tissue, however, D-chiro-inositol does the opposite of myo-inositol: it promotes androgen production and suppresses aromatase. This is why the balance between the two forms matters so much.
Why the 40:1 Ratio Matters
Your body converts myo-inositol into D-chiro-inositol using an enzyme called epimerase, and this conversion is driven by insulin. In healthy people, the ratio of myo to D-chiro-inositol in blood plasma sits around 40:1. Different tissues maintain different ratios depending on their needs. Ovarian tissue, for example, runs closer to 100:1 because it relies heavily on myo-inositol for FSH signaling and egg development.
Insulin resistance disrupts this system. In animal studies of type 2 diabetes, epimerase activity dropped two to threefold, leading to a four to fivefold decrease in the conversion of myo-inositol to D-chiro-inositol. The result is a paradox: some tissues end up starved of D-chiro-inositol while others, particularly the ovaries, may accumulate too much relative to myo-inositol. This imbalance can worsen both metabolic and hormonal problems.
Supplementing D-chiro-inositol alone, especially at high doses, has been shown to backfire. In one study, 1,200 mg per day of D-chiro-inositol significantly increased testosterone levels. That’s the opposite of what most people supplementing inositol are trying to achieve. The 40:1 combination restores the natural plasma ratio without flooding hormone-sensitive tissues with excess D-chiro-inositol.
Effects on PCOS and Hormonal Balance
The strongest evidence for inositol supplementation comes from research on polycystic ovary syndrome (PCOS), a condition driven largely by insulin resistance and excess androgens. A systematic review and meta-analysis of randomized controlled trials found that inositol treatment made women 1.79 times more likely to regain regular menstrual cycles compared to placebo. The effect on menstrual regularity was comparable to metformin, the most commonly prescribed drug for insulin-related PCOS symptoms.
Androgen levels also improved across multiple trials. Total testosterone dropped by an average of about 20 ng/dL, free testosterone fell by 0.41 ng/dL, and androstenedione (another androgen) decreased by 0.69 ng/mL. Inositol also increased levels of sex hormone-binding globulin (SHBG), a protein that binds to testosterone and reduces its activity in the body. Together, these shifts address the hormonal profile that drives many PCOS symptoms like acne, excess hair growth, and irregular ovulation.
Myo-inositol supplementation specifically has been shown to lower the LH-to-FSH ratio, a hormonal imbalance characteristic of PCOS that interferes with normal follicle development and ovulation.
Impact on Metabolic Health
Beyond hormones, inositol supplementation produces measurable changes in metabolic markers. A large meta-analysis of randomized controlled trials found the following average improvements compared to placebo:
- Fasting glucose: reduced by 7.25 mg/dL
- Fasting insulin: reduced by 4.74 µU/mL
- Insulin resistance (HOMA-IR): reduced by 1.21 points
- Triglycerides: reduced by about 30 mg/dL
- Total cholesterol: reduced by about 18 mg/dL
- LDL cholesterol: reduced by about 5 mg/dL
- HDL cholesterol: increased by about 3 mg/dL
The insulin and HOMA-IR reductions had moderate evidence certainty, while the triglyceride and cholesterol improvements showed high variability between studies. Still, the direction of effect was consistently positive across trials. These metabolic benefits are relevant not just for PCOS but for anyone dealing with insulin resistance or metabolic syndrome.
Fertility and Egg Quality
Inositol’s role in FSH signaling makes it particularly relevant for fertility. In women undergoing IVF, myo-inositol supplementation started three months before ovarian stimulation reduced the amount of injectable hormones needed for adequate follicle development. It also lowered the risk of ovarian hyperstimulation syndrome and decreased the number of canceled cycles.
The quality of eggs retrieved also improved. Clinical trials consistently show that myo-inositol reduces the number of degenerated and immature eggs, which translates into better embryo quality after fertilization. In one study of 50 overweight women with PCOS, those who took 2 g of myo-inositol daily for 12 weeks had a clinical pregnancy rate of 60%, compared to 32% in the control group. Research combining myo-inositol with melatonin in IVF protocols has shown a synergistic improvement in both egg and embryo quality.
Typical Dosing in Clinical Research
The most commonly studied dose is 4,000 mg (4 g) of myo-inositol per day, usually split into two doses of 2 g. When combined with D-chiro-inositol in the 40:1 ratio, that works out to roughly 100 mg of D-chiro-inositol daily. Most commercial supplements follow this formulation, often with added folic acid (typically 200 to 400 mcg). Clinical trials generally run for 12 weeks or longer before assessing outcomes, so benefits aren’t immediate.
Side Effects and Tolerability
Inositol is generally well tolerated at the doses used in research. The most common side effects are mild and digestive: nausea, diarrhea, and abdominal discomfort. Some people also report fatigue, headache, or dizziness, though these are less frequent. Side effects tend to be more common at higher doses and often improve as your body adjusts. Starting with a lower dose and increasing gradually can help minimize GI discomfort.